Login
$SVRN
$31.62 -$3.70 (10.48%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents (Note 2(e))
Due from a related party
Due from a related party (Note 3(a))
Accounts receivable trade, net (Note 2(f))
Inventories (Note 2(g))
Prepaid expenses and other assets, net (Note 6)
Insurance claims (Note 2(i))
Total current assets
FIXED ASSETS:
Vessels, net (Notes 2(j), 2(l) and 5)
Total fixed assets
OTHER NON-CURRENT ASSETS:
Deferred charges, net (Note 2(n))
Equity method investment (Notes 2(h) and 4)
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable, trade and other
Due to related parties
Due to related parties (Notes 3(a),3(b), and 3(h))
Dividends payable (Note 7(c))
Accrued liabilities
Unearned revenue (Note 2(o))
Unearned revenue (Note 2(p))
Total current liabilities
STOCKHOLDERS' EQUITY:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, 533,136 issued and outstanding as of December 31, 2024, and 520,459 issued and outstanding as of December 31, 2023 (Note 7)
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 7,504,982 issued and outstanding as of December 31, 2024, and 7,448,601 issued and outstanding as of December 31, 2023 (Note 7)
Additional paid-in capital (Note 7)
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support